Kaynaklar: (1) Access SARS-CoV-2 IgM testinin özgüllüğü, Fransa ve Amerika Birleşik Devletleri’nde Aralık 2019 öncesi toplanan 1.400 örnek üzerinde yapılan bir çalışmada değerlendirilmiştir. (Access SARS-CoV-2 IgM Kullanım Kılavuzu) (2) Sonuç non-reaktif (<10 AU/mL) veye reaktif (>/=10 AU/mL) olarak görünecektir (Access SARS-CoV-2 IgG II IFU) (3) Access SARS-CoV-2 IgM Kullanım Kılavuzu, Access SARS-CoV-2 IgG Kullanım Kılavuzu (4) Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L. "Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine." Cell Mol Immunol. 2020 Mar 19. doi: 10.1038/s41423-020-0400 https://www.nature.com/articles/s41423-020-0400-4 (5) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274253/  (6) World Health Organization COVID-19 virtual press conference - 10 April, 2020 : https://www.who.int/docs/default-source/coronaviruse/transcripts/novel-coronavirus-landscape-ncov-11april2020.pdf?sfvrsn=ac0b3c1d_6 (7) Xiao, A., Tong, Y., & Zhang, S. (2020, July 11). False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence. Retrieved August 03, 2020, from https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25855 (8) Ercolano, A. (2020, July 23). Coronavirus Research: Johns Hopkins Medicine. Retrieved July 28, 2020, from https://www.hopkinsmedicine.org/coronavirus/coronavirus-research/ (9) Kucirka, L., Lauer, S., Laeyendecker, O., Boon, D., Lessler, J., & M. Centor, R. (2020, June 16). Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure. Retrieved August 03, 2020, from https://www.acpjournals.org/doi/10.7326/M20-1495 (10) Xiao, Ai Tang et al. "False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence” Journal of Medical Virology, First published: 09 April 2020 https://doi.org/10.1002/jmv.25855 (11) Chen, Y., & Li, L. (2020, March 23). SARS-CoV-2: Virus dynamics and host response. Retrieved August 03, 2020, from https://doi.org/10.1016/S1473-3099(20)30235-8 (12) Long, Q., Liu, B., Deng, H. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med (2020). https://doi.org/10.1038/s41591-020-0897-1 (13) Partners In Health Guide | COVID-19. Part I: Testing, Contact Tracing and Community Management of COVID-19. Updated 20 March 2020. https://www.pih.org/sites/default/files/2020-03/PIH_Guide_COVID_Part_I_Testing_Tracing_Community_Managment_3_21.pdf, Accessed: May 7,2020 (14) Ling Ni, Fang Ye, Meng-Li Cheng, Yu Feng, Yong-Qiang Deng, Hui Zhao, Peng Wei, Jiwan Ge, Mengting Gou, Xiaoli Li, Lin Sun, Tianshu Cao, Pengzhi Wang, Chao Zhou, Rongrong Zhang, Peng Liang, Han Guo, Xinquan Wang, Cheng-Feng Qin, Fang Chen, Chen Dong. “Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals” https://doi.org/10.1016/j.immuni.2020.04.023